Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801263200 on February 25, 2008

J. Biol. Chem., Vol. 283, Issue 16, 10753-10763, April 18, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/16/10753    most recent
M801263200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. I.
Right arrow Articles by Choi, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. I.
Right arrow Articles by Choi, M. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Phosphatase 2A Is a Negative Regulator of Transforming Growth Factor-β1-induced TAK1 Activation in Mesangial Cells*

Sung Il Kim{ddagger}§1, Joon Hyeok Kwak{ddagger}§1, Lin Wang{ddagger}, and Mary E. Choi{ddagger}§2

From the {ddagger}Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213 and the §Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115

TAK1 (transforming growth factor (TGF)-β-activated kinase 1) is a serine/threonine kinase that is rapidly activated by TGF-β1 and plays a vital function in its signal transduction. Once TAK1 is activated, efficient down-regulation of TAK1 activity is important to prevent excessive TGF-β1 responses. The regulatory mechanism of TAK1 inactivation following TGF-β1 stimulation has not been elucidated. Here we demonstrate that protein phosphatase 2A (PP2A) plays a pivotal role as a negative regulator of TAK1 activation in response to TGF-β1 in mesangial cells. Treatment with okadaic acid (OA) induces autophosphorylation of Thr-187 in the activation loop of TAK1. In vitro dephosphorylation assay suggests that Thr-187 in TAK1 is a major dephosphorylation target of PP2A. TGF-β1 stimulation rapidly activates TAK1 in a biphasic manner, indicating that TGF-β1-induced TAK1 activation is tightly regulated. The association of PP2AC with TAK1 is enhanced in response to TGF-β1 stimulation and closely parallels TGF-β1-induced TAK1 activity. Attenuation of PP2A activity by OA treatment or targeted knockdown of PP2AC with small interfering RNA enhances TGF-β1-induced phosphorylation of TAK1 at Thr-187 and MKK3 (MAPK kinase 3). Endogenous TAK1 co-precipitates with PP2AC but not PP6C, another OA-sensitive protein phosphatase, and knockdown of PP6C by small interfering RNA does not affect TGF-β1-induced phosphorylation of TAK1 at Thr-187 and MKK3. Moreover, ectopic expression of phosphatase-deficient PP2AC enhances TAK1-mediated MKK3 phosphorylation by TGF-β1 stimulation, whereas the expression of wild-type PP2AC suppresses the MKK3 phosphorylation. Taken together, our data indicate that PP2A functions as a negative regulator in TGF-β1-induced TAK1 activation.


Received for publication, February 15, 2008

* This work was supported in part by NIDDK, National Institutes of Health, Grant R01 DK57661 and the M. James Scherbenske Grant from the American Society of Nephrology (to M. E. C.) and Beginning Grant-in-Aid 0665379U from the American Heart Association (to S. I. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both of these authors contributed equally to this work.

2 To whom correspondence should be addressed: Renal Division, Brigham and Women's Hospital, Dept. of Medicine, Harvard Medical School, 4 Blackfan Circle, HIM-5, Boston, MA 02115. Fax: 617-525-5923; E-mail: mchoi{at}rics.bwh.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. H. Kwak, S. I. Kim, J. K. Kim, and M. E. Choi
BAT3 Interacts with Transforming Growth Factor-{beta} (TGF-{beta}) Receptors and Enhances TGF-{beta}1-induced Type I Collagen Expression in Mesangial Cells
J. Biol. Chem., July 11, 2008; 283(28): 19816 - 19825.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement